Study on Perimenopause-Related Mood Disorders Examines Hormonal Impact
An observational study will investigate the relationship between hormonal changes and mood disorders in perimenopausal women.
Phase III
Psychiatry / Mood Disorders
Status
Active
Sponsor
mental health pharmaceutical companies
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
This study is significant as it explores the hormonal influences on mood disorders in perimenopausal women, a demographic that is often underserved in mental health treatment. The findings could lead to new therapeutic approaches, impacting the competitive landscape in the mental health space.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor results from this study and companion studies testing antidepressant efficacy of phytoestrogens and SERMs.
Related companies & assets
Assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.